Barclays Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $162
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic maintains an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) and raises the price target from $158 to $162.
October 12, 2023 | 6:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Equal-Weight rating on Johnson & Johnson and raises the price target from $158 to $162.
The raised price target by Barclays indicates a positive outlook for Johnson & Johnson. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100